AICDA and lymphoma: With AID implicated in misappropriated translocations and mutations in lymphoma, vIL-6 may also play a role in KSHV pathogenesis and the development of KSHV-lymphoproliferative disorders and primary effusion lymphoma (PEL), the main type of KSHV-associated lymphoma.